Researchers set out to determine whether attention-deficit/hyperactivity disorder predisposes individuals to the development of neuropsychiatric symptoms. The researchers presented their findings at the...
In a multicenter, retrospective study, researchers evaluated time from NMOSD onset to serological diagnosis and factors associated with predicting shorter time to diagnosis.
Researchers sought to determine the efficacy of brexpiprazole in reducing agitation symptoms in patients with dementia due to Alzheimer disease. The results were presented at the Alzheimer Association...
Researchers evaluated the association between neuropsychiatric symptoms, such as agitation and apathy, in patients with Alzheimer disease and the rate of functional decline.
Researchers used data from the Alzheimer's Disease Neuroimaging Initiative database to identify specific brain regions associated with hyperactive neuropsychiatric symptoms among patients with mild...
Researchers examining patients with late-stage dementia and significant agitation, found that a wearable device such as a wrist-worn actigraphy could be a feasible behavior-monitoring tool to assess sleep...
Researchers set out to determine the associations between self- and partner-reported cognitive decline and tau and β-amyloid levels among cognitively unimpaired individuals.
A systematic review and meta-analysis examined the clinical differences between adult patients with neuromyelitis optica spectrum disorders and those with multiple sclerosis.
